Form 4: Supernus Pharmaceuticals Executive Exercises Options and Sells Shares

Frank Mottola, SVP at Supernus Pharmaceuticals, exercised stock options and sold 15,000 shares of common stock on November 7, 2024.

Summary

• Frank Mottola, a Senior Vice President at Supernus Pharmaceuticals, executed a transaction involving the company's stock on November 7, 2024.
• Mottola exercised options to purchase 15,000 shares of common stock at a price of $9.13 per share.
• Simultaneously, Mottola sold 15,000 shares at a weighted average price of $36.98, with individual sales ranging from $36.73 to $37.27.
• Following these transactions, Mottola directly owns 8,200 shares of Supernus Pharmaceuticals common stock.
• The exercised options were part of an employee stock option plan that vested in equal installments starting March 3, 2016.
• Mottola also acquired 421 shares through the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reflects a standard executive stock transaction. The sale could be seen as slightly negative, but it's a common practice.

Positives

• The exercise of options and subsequent sale of shares indicates Mottola's belief in the company's value, at least at the time the options were granted.

Negatives

• The sale of shares by an executive could be interpreted negatively by some investors, although it is a common practice.

Risks

• Executive stock sales can sometimes signal a lack of confidence in the company's future performance, although this is not necessarily the case here.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are subject to regulatory oversight to prevent insider trading. Form 4 filings are a standard part of this oversight.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The vesting schedule and exercise price of these options are typically benchmarked against industry standards and company performance.
• The sale of shares after exercising options is a common practice, especially as options approach their expiration date.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• Shareholders may be interested in executive stock transactions as an indicator of management's confidence.

Key Dates